NDC codes

FDA NDC Directory
Product NDC (as listed)73606-020Labeler and product segments. Claims need a package NDC.
Product NDC at billing width73606-0020Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
73606-020-01736060020011 VIAL, GLASS in 1 CARTON (73606-020-01) / 3 mL in 1 VIAL, GLASSMarketed from Feb 17, 2023
73606-020-02736060020021 VIAL, GLASS in 1 CARTON (73606-020-02) / 3 mL in 1 VIAL, GLASSMarketed from Nov 7, 2025
73606-020-11736060020111 VIAL, GLASS in 1 CARTON (73606-020-11) / 3 mL in 1 VIAL, GLASSMarketed from Feb 17, 2023 · Sample package
73606-020-12736060020121 VIAL, GLASS in 1 CARTON (73606-020-12) / 3 mL in 1 VIAL, GLASSMarketed from Nov 7, 2025 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Syfovre
Generic name (nonproprietary)
pegcetacoplan
Active ingredients
Pegcetacoplan — 15 mg/.1mL
Dosage form
Injection, Solution
Route
Intravitreal
Labeler
Apellis Pharmaceuticals, Inc.NDC labeler code 73606
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 217171
Marketing start
Listing expires
Other FDA classes
Complement Inhibitors (Mechanism)
Identifiers
Product ID 73606-020_76e1d7d9-903f-49c1-be3a-617f682e79e7SPL ID 76e1d7d9-903f-49c1-be3a-617f682e79e7SPL set ID b4434e61-9ec9-4e0e-bd60-45aaa0a87e64RxCUI 2630847, 2630853UNII TO3JYR3BOU
Pharmacologic class
Complement Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N473606002001 followed by a unit qualifier and the quantity

Package 73606-0020-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

SYFOVRE is indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). SYFOVRE is a complement inhibitor indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 73606-020

What is NDC 73606-020?
73606-020 is the product NDC for Syfovre (pegcetacoplan), Pegcetacoplan 15 mg/.1mL injection, solution, listed with the FDA by Apellis Pharmaceuticals, Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Syfovre (Pegcetacoplan).
What is the active ingredient?
Pegcetacoplan.
Who is the labeler?
Apellis Pharmaceuticals, Inc., NDC labeler code 73606. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Syfovre?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in